Covid-19
Revisão | COVID-19 em crianças.
12 Set, 2022 | 11:35hCOVID-19 in Children – Pediatric Clinics of North America
Diretriz de consenso | Rastreamento cardíaco antes do retorno aos jogos após infecção por SARS-CoV-2 em crianças e adolescentes atletas. – “Indivíduos assintomáticos e aqueles com sintomas leves devem ser liberados pela atenção primária ou pelo médico da equipe após exame físico e avaliação acurada do histórico médico.”
8 Set, 2022 | 13:59h
M-A | Segurança e eficácia do abacavir no tratamento de bebês, crianças e adolescentes vivendo com HIV.
8 Set, 2022 | 13:45h
Comentário no Twitter
*New meta-analysis* supports the use of #abacavir as a preferred first-line regimen for infants & children living with #HIV
By @jujesson & colleagueshttps://t.co/WSvp5ZOUf1 pic.twitter.com/qFBo5O3zJC
— The Lancet Child & Adolescent Health (@LancetChildAdol) September 5, 2022
Perspectiva | Ciência, valores concorrentes e risco-benefício na saúde pública – o exemplo da Covid-19 e do uso de máscara.
6 Set, 2022 | 13:12h
FDA autoriza doses de reforço atualizadas para novas variantes do COVID com vacinas da Moderna e da Pfizer.
6 Set, 2022 | 13:11hFDA authorizes updated COVID boosters from Moderna and Pfizer – CIDRAP
Comunicado de imprensa do FDA: Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose – U.S. Food & Drug Administration
Estudo de coorte retrospectiva | Uso de nirmatrelvir e desfechos de Covid-19 grave durante o aumento da variante Ômicron.
29 Ago, 2022 | 17:16h
Comentário no Twitter
During the clinical rollout of nirmatrelvir in Israel in early 2022, most patients (78%) had previous SARS-CoV-2 immunity. Benefit was seen among patients at highest risk for Covid-19 progression, such as those 65+. https://t.co/O6CxzDdIfH pic.twitter.com/ccCaCCh15i
— NEJM (@NEJM) August 24, 2022
Estudo de coorte retrospectiva | Fatores de risco clínico e genético para tromboembolismo venoso incidental agudo em pacientes ambulatoriais com COVID-19.
29 Ago, 2022 | 16:42h
Comentário no Twitter
Ambulatory #COVID19 was associated with a substantially increased risk of incident venous thromboembolism, but this risk was greatly reduced in fully vaccinated people with breakthrough infection. https://t.co/98zKNfEWaU #Research
— JAMA Internal Medicine (@JAMAInternalMed) August 18, 2022
Estudo de coorte retrospectiva | Associação de COVID-19 vs. Influenza com risco de eventos trombóticos venosos e arteriais entre pacientes hospitalizados.
29 Ago, 2022 | 16:41hComentário: Higher risk of vein blood clots in COVID vs flu patients – CIDRAP
Comunicado de imprensa: People with Severe COVID-19 Face Increased Risk of Life-Threatening Blood Clots – Penn Medicine News
Comentário no Twitter
The risk of blood clots in hospitalized patients with Covid vs influenza was increased 60-90% within 90 days, for venous but not arterial thrombosishttps://t.co/wPHf18NYYB @JAMA_current
Retrospective, much smaller influenza cohort from 2018-2019 pic.twitter.com/sClYHF0J6U— Eric Topol (@EricTopol) August 16, 2022
Revisão sistemática atualizada e avaliação crítica | Modelos preditivos para diagnóstico e prognóstico de Covid-19.
29 Ago, 2022 | 14:08hComentário: Update to living systematic review on prediction models for diagnosis and prognosis of covid-19 – The BMJ
Comentário no Twitter
NEW update in @bmj_latest
606 prognostic models for #COVID19 identified – 29 had low risk of bias, 32 had unclear risk of bias, AND 545 HAD HIGH RISK OF BIAS!
+Poorly reported – use TRIPOD please https://t.co/tVA0xHXdRu#epitwitter #statstwitter pic.twitter.com/n71vdgY8wM
— Gary Collins 🇪🇺 (@GSCollins) August 22, 2022
Risco de miocardite após doses sequenciais de vacina contra COVID-19 vs. após infecção pelo SARS-CoV-2 conforme idade e sexo.
29 Ago, 2022 | 14:00hComunicado de imprensa: Myocarditis risk significantly higher after COVID-19 infection vs. after a COVID-19 vaccine – Circulation